SOURCE: Acology Inc.

Acology Inc.

January 28, 2015 08:00 ET

Acology Announces New Advisory Board Member

CORONA CA--(Marketwired - January 28, 2015) - Acology Inc. (OTCQB: ACOL) is very pleased to announce the addition of Ms. Mieko Hester-Perez to its Advisory Board. Ms. Hester-Perez brings unique qualifications to Acology.  In addition to being a board member of NORML's Women's Alliance, Ms. Hester-Perez is the co-founder of the Unconventional Foundation for Autism. (www.UF4A.Org) Ms. Hester-Perez's informational website raises awareness and support for the families of children stricken with this mysterious and misunderstood disease. She will become a spokesperson for Acology on the importance of legally compliant packaging and the effectiveness of Acology products.

In announcing her new status as an Advisory Board Member, Ms. Hester-Perez says "I'm very pleased to be associated with Acology Inc and to communicate my enthusiasm and appreciation for their products. Legal, compliant packaging is certainly one of the cornerstones of effective therapy. I am continually impressed with Acology's commitment to innovation and ethics. We share common goals and I'm looking forward to the next 2 years with confidence and determination."

Ms. Hester-Perez's information website raises awareness specifically to assist in providing comprehensive data on the clinical use of cannabinoids to treat autism symptoms. In joining Acology on its Advisory Board Ms. Hester-Perez, as the mother of a severely autistic son, presents a unique insight to the growing phenomenon of effective treatment modalities based on cannabinoid extractions and their use in autism case studies. Ms. Hester-Perez works diligently on medical and legal frontlines to create a national focus that sheds light on new treatment options for this potentially devastating condition. She has teamed up with Acology Inc. (OTCQB: ACOL) to package a specific new strain of cannabis. Acology's creative team has designed a custom "Joey's Strain" logo which will be placed on its own MedTainer. The Medtainer was chosen for its exclusive child-resistant, patented polypropylene bottle.

All involved agree on the importance of providing industry-leading, compliant packaging of medical cannabis products to this new patient base and families in households who have been touched by autism. Thus, as "Joey's Strain" becomes available in other states, the medication will be packaged with a Medtainer and its distinctive "Joey's Strain" logo.

Ms. Hester-Perez will advise Acology as the company moves forward with plans to support and enhance more worthy causes and create innovative ways to join research and treatment solutions to Acology products.

Acology has launched into 2015 aggressively by executing plans to develop new market opportunities for its products. Sales of Acology products eclipsed 2014 expectations. 

Acology's 4th and 5th generation Medtainers are patented, FDA approved #5 polypropylene containers that are water-proof, smell-proof and child resistant. The Medtainers most impressive feature is a built-in grinder that grinds pills, herbal medications, coffee beans and teas into fine powder. The container's grinding teeth have been reinforced for greater wear and maximum results.

Acology Inc. is located in their new production facility at 1620 A Commerce Street, Corona, California, 92880. Acology trades on the OTCQB as ACOL. Contact them at info@acologyinc.com or call (844) ACOLOGY .

For more information on Acology, Inc.: www.acologyinc.com

For more information on the Medtainer: www.themedtainer.com 

About Acology Inc.

Acology, Inc. is a revolutionary bottle design, manufacturing, branding and sales company bringing to the forefront the first-ever polypropylene (PP) airtight, watertight, smell-proof delivery and storage system with a built-in grinding component. Acology containers give consumers the ability to easily store, carry and consume herbal remedies, pharmaceuticals, teas and any other solid or liquid content. Because Acology Inc. adheres so closely to the rigid compliance standards of the medical industry it can provide the medical professional with the ability to store, mix and distribute medications in solid form without the fear of cross-contamination. 

Safe Harbor Statement

This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. 

Contact Information